New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo

BACKGROUND: The 2013-2014 approvals of new direct-acting antiviral (DAA) therapies for hepatitis C virus (HCV) infection have engendered a paradigm shift in HCV treatment and management, offering the potential for a cure at a population level. The availability of the highly effective and relatively...

Descripción completa

Detalles Bibliográficos

Autores principales:	Terrault, Norah, Monto, Alex, Stinchon, Michael R., Rusie, Erica, Moreo, Kathleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2015
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408779/ https://www.ncbi.nlm.nih.gov/pubmed/26308363 http://dx.doi.org/10.18553/jmcp.2015.21.9.S1